A Study to Evaluate the Relative Bioavailability of Ruxolitinib Extended Release (XR) Tablets Compared With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants.
Clinical trial NCT06310304 · COMPLETED
Trial details
- NCT number
- NCT06310304
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-26
- Primary completion
- 2024-04-16
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.